Manufacturer record
Saphnix Life Sciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Saphnix Life Sciences (Himachal Pradesh) were declared Not of Standard Quality between November 2024 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to Saphnix Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aceclofenac (SR) & Rabeprazole Sodium (EC) Capsules | YC337AMfg 2025-07 · Exp 2027-06 | The sample does not conform to Manufacturer's Specification with respect to the test of Dissolution of Rabeprazole Sodium in buffer stageDissolution | CDL, KolkataCDSCO lab | May 2026 |
| Levosalbutamol, Ambroxol HCL & Guaiphenesin Syrup | XL983Mfg 2024-09 · Exp 2026-08 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Ambroxol HCl, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup) | XL1625Mfg 2024-11 · Exp 2026-10 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Nov 2025 |
| Rifaximin Tab 400 mg. | XT2656FMfg 2025-11 · Exp 2026-10 | MISBRANDEDMisbranded | State Lab, Drugs Control Laboratory, TelanganaState lab | Aug 2025 |
| Retrazith-250 | WT3927FMfg 2024-03 · Exp 2026-02 | Sample does not conform to IP specification for Azithromycin Tablets with respect to Dissolution and to the Content of Anhydrous Azithromycin Dihydrate.Dissolution | DTL ChennaiState lab | Dec 2024 |
| Itraconazole Capsules B.P. 200 mg (It-Bert 200) | WC819CMfg 2023-11 · Exp 2025-10 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Nov 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.